Always patient and willing to help.
Yee Syuen Low holds a Bachelor of Biomedical Sciences (BBiomedSc) and a PhD from the University of Otago's Wellington School of Medicine and Health Sciences, completed in 2019. She worked as a Laboratory Scientist in the Department of Pathology and Molecular Medicine, University of Otago, Wellington, where she contributed to research on molecular pathology, cancer cell biology, and genomic instability. Her role involved supporting investigations, project administration, and experimental work in a department focused on advancing knowledge in disease mechanisms through pathological and molecular approaches.
Low's publications highlight her expertise in cancer genomics and pathogen diagnostics. In "Chromosomal instability and its effect on cell lines" (Cancer Reports, 2023), she supported investigations into how chromosomal variations affect the reliability of cancer cell lines as biomedical models. She contributed to experimental design, data acquisition, analysis, and drafting for "KRAS-specific antibody binds to KRAS protein inside colorectal adenocarcinoma cells and inhibits its localization to the plasma membrane" (Frontiers in Oncology, 2023), with her affiliation at the Department of Pathology and Molecular Medicine. As corresponding author and lead investigator for "Development of a portable avian influenza virus characterisation system: bringing the inside-out" (Scientific Reports, 2025), she designed and supervised the integration of portable RNA extraction, sequencing, and bioinformatics for rapid field identification of avian influenza subtypes and pathogenicity. Additional works include a formalin-fixed paraffin-embedded-based prognostic signature to predict metastasis in colorectal adenomas (Cancer Genetics, 2017) and a genome-wide association study identifying copy number variants associated with sporadic colorectal cancer risk (Journal of Medical Genetics, 2018). Her research spans cancer model validation and innovative surveillance tools for infectious diseases.
